https://www.marketscreener.com/quote/stock/BRII-BIOSCIENCES-LIMITED-124598684/news/Brii-Biosciences-Announces-Top-line-Results-from-Phase-1-Study-of-BRII-296-A-Long-Acting-Therapy-in-41860467/?utm_source=telegram&utm_medium=social&utm_campaign=share